Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

101760

registered interest
date	30/10/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Biotechnology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what steps his Department is taking to promote the UK as a location of choice for life science investment in trade missions.
tabling member constituency	Salisbury
tabling member printed	John Glen
uin	212638
answer	answer is ministerial correction date of answer 07/11/2014 answer text <p>The Life Sciences Organisation (LSO), sitting within UK Trade and Investment (UKTI), is responsible for promoting the UK as an investment destination for life sciences, as well as supporting UK companies to increase exports to other markets. The team comprises a mixture of industry specialists and experienced civil servants, who together provide a range of support to potential investors and exporters.</p><p> </p><p>The LSO has developed a suite of marketing materials that showcase the UK’s life sciences capabilities across a number of priority sub-sectors, including but not limited to pharmaceutical manufacturing, regenerative medicine and experimental medicine &amp; clinical trials. Within each theme the LSO promotes the UK through direct, in-market company visits and/or tailored events and activities around the world, and works with international companies that would be well placed to take advantage of the UK offer. In 2013/14, the Life Sciences Organisation delivered 136 FDI projects creating or safeguarding more than 3,500 jobs.</p><p> </p> answering member constituency West Suffolk answering member printed Matthew Hancock question first answered 07/11/2014 14:43:43 answering member 4070 label Biography information for Matt Hancock
tabling member	4051 label Biography information for John Glen

101761

registered interest
date	30/10/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Biotechnology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what estimate he has made of the number of jobs in each region and constituent part of the UK which are supported by the life science industry.
tabling member constituency	Salisbury
tabling member printed	John Glen
uin	212639
answer	answer is ministerial correction date of answer 07/11/2014 answer text <p>There are no published official statistics on the regional distribution of life science industry jobs. The table below includes an estimate of employment in 2013 in companies active in three “health life science” sectors: Medical Biotechnology, Medical Technology and Pharmaceuticals, by region and by constituent part of the UK, obtained from the Bioscience and Health Technology company database used by the Office for Life Sciences. The figures are based on locations of active sites for which employment figures can be obtained. They do not include those employed by public or third sector organisations nor employment in companies whose main activity falls outside life sciences, including indirect suppliers to the sector.</p><p> </p><table><tbody><tr><td> </td><td><p><strong>Number of employees in health life science industry ‘000s 2013</strong></p></td></tr><tr><td><p>East Midlands</p></td><td><p>9.5</p></td></tr><tr><td><p>East of England</p></td><td><p>28.8</p></td></tr><tr><td><p>Greater London</p></td><td><p>13.6</p></td></tr><tr><td><p>North East England</p></td><td><p>7.1</p></td></tr><tr><td><p>North West England</p></td><td><p>17.0</p></td></tr><tr><td><p>South East England</p></td><td><p>36.8</p></td></tr><tr><td><p>South West England</p></td><td><p>8.2</p></td></tr><tr><td><p>West Midlands</p></td><td><p>14.5</p></td></tr><tr><td><p>Yorkshire and the Humber</p></td><td><p>13.5</p></td></tr><tr><td><p>England total</p></td><td><p>149.0</p></td></tr><tr><td> </td><td> </td></tr><tr><td><p>Northern Ireland</p></td><td><p>4.3</p></td></tr><tr><td><p>Scotland</p></td><td><p>11.5</p></td></tr><tr><td><p>Wales</p></td><td><p>9.1</p></td></tr><tr><td><p>UK Total</p></td><td><p>173.9</p></td></tr></tbody></table><p>Source: Bioscience and Health Technology database, an annual summary of the data was published as “Strength and Opportunity 2013, the landscape of the medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors in the UK”</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 07/11/2014 16:53:00 answering member 4020 label Biography information for George Freeman
tabling member	4051 label Biography information for John Glen

101774

registered interest
date	30/10/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Biotechnology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what comparative assessment he has made of the competitiveness of the (a) UK, (b) France, (c) Germany, (d) China and (e) US life science industry.
tabling member constituency	Salisbury
tabling member printed	John Glen
uin	212635
answer	answer is ministerial correction date of answer 11/11/2014 answer text <p>The UK pharmaceutical sector contributes more than £13 billion to UK Gross Value Added (GVA), making it the second largest in Europe after Germany measured by GVA. The life sciences sector employs 173,900 people in the UK, and the UK is second only to the US measured by the share of top 1% citations in life science related subjects. The Office of Life Sciences is currently developing a set of indicators reflecting the broad competitiveness of the UK life science environment against key international comparators.</p><p> </p><p>More broadly, the most recent Global Competitiveness Report by the World Economic Forum (WEF) overall ranks the UK within the top 10 competitive countries in which to conduct business, continuing its historical strong performance. The UK is well regarded for its high quality science and research base, high-level skills, openness to international trade and effectiveness of its regulatory and competition regimes and flexible labour market. As a result the UK overall remains a magnet for inward investment, second only to the USA.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/11/2014 12:46:09 answering member 4020 label Biography information for George Freeman
tabling member	4051 label Biography information for John Glen

101775

registered interest
date	30/10/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Biotechnology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what structures his Department has in place to ensure that (a) the Life Sciences Organisation and (b) the Office for Life Sciences co-ordinate with the MHRA and National Institute of Health and Care Excellence.
tabling member constituency	Salisbury
tabling member printed	John Glen
uin	212636
answer	answer is ministerial correction date of answer 11/11/2014 answer text <p>Since April 2014 the Office for Life Sciences (OLS) has operated as a joint Director-led unit between the Department of Business Innovation and Skills and the Department of Health. The previous good working relationships between the OLS and MHRA and NICE have been strengthened through this move, as all these bodies are now either part of or sponsored by the Department of Health and all three fall within my Ministerial portfolio.</p><p> </p><p>The UKTI Life Sciences Organisation (LSO) also has strong working relationships with MHRA and NICE, both directly and through the OLS, largely operating on an informal basis rather than within particular structures.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/11/2014 11:48:16 answering member 4020 label Biography information for George Freeman
tabling member	4051 label Biography information for John Glen

101871

registered interest
date	30/10/2014
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Iran
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, what representations his Department has made to the Iranian government on the imprisonment of (a) Ebrahim Firouzi, (b) Shahin Lahooti, (c) Suroush Saraie and (d) Mohammad Roghangir.
tabling member constituency	Salisbury
tabling member printed	John Glen
uin	212637
answer	answer is ministerial correction date of answer 05/11/2014 answer text <p>We remain deeply concerned by the detention of all prisoners of conscience in Iran, and by the ongoing discrimination against Christians and other minority religious groups. We have called for the Iranian government to protect the rights of all minority groups in Iran and to end the persecution of individuals on the basis of their faith, most recently during our representations to the United Nations Human Rights Council during the Universal Periodic Review of Human Rights in Iran on 31 October.</p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood question first answered 05/11/2014 15:36:39 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	4051 label Biography information for John Glen